Funding agencies: The project described was supported by Award Numbers U01DK048489, R01DK083297, and K23DK071552 from The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK provided funding to the clinical centers and the Coordinating Center for the design and conduct of the study; collection, management, analysis, and interpretation of the DPP. The Southwestern American Indian Centers were supported directly by the NIDDK and the Indian Health Service. The General Clinical Research Center Program, National Center for Research Resources supported data collection at many of the clinical centers. Funding for data collection and participant support was also provided by the National Institute of Child Health and Human Development, the National Institute on Aging, the Office of Research on Women's Health, the Office of Research on Minority Health, the Centers for Disease Control and Prevention, and the American Diabetes Association. Bristol-Myers Squibb and Parke-Davis provided medication. This research was also supported, in part, by the intramural research program of the NIDDK. LifeScan Inc., Health O Meter, Hoechst Marion Roussel, Inc., Merck-Medco Managed Care, Inc., Merck and Co., Nike Sports Marketing, Slim Fast Foods Co., and Quaker Oats Co. donated materials, equipment, or medicines for concomitant conditions. McKesson BioServices Corp., Matthews Media Group, Inc., and the Henry M. Jackson Foundation provided support services under subcontract with the Coordinating Center. The opinions expressed are those of the investigators and do not necessarily reflect the views of the Indian Health Service or other funding agencies.
Sex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention program
Version of Record online: 22 AUG 2013
Copyright © 2013 The Obesity Society
Volume 22, Issue 3, pages 882–887, March 2014
How to Cite
Kim, C., Barrett-Connor, E., Randolph, J. F., Kong, S., Nan, B., Mather, K. J., Golden, S. H. and the Diabetes Prevention Program Research Group (2014), Sex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention program. Obesity, 22: 882–887. doi: 10.1002/oby.20527
Author contributions: C.K. performed the literature search and drafted the manuscript and figures. E.B.C. contributed to the study design, data collection, data interpretation, and reviewed the manuscript draft. J.F.R. assisted in data interpretation. S.K. performed the data analyses. B.N. interpreted the data analyses. K.M. assisted in data collection. S.G. conceived of the study and assisted in data interpretation. All authors were involved in reviewing manuscript drafts and had final approval of the submitted and published versions.
Conflicts of interest: The authors declared no conflict of interest.
- Issue online: 5 MAR 2014
- Version of Record online: 22 AUG 2013
- Accepted manuscript online: 26 JUN 2013 12:38PM EST
- Manuscript Accepted: 3 JUN 2013
- Manuscript Received: 6 FEB 2013
- 1Oestrogen and progestogen hormone replacement therapy for perimenopausal and postmenopausal women: weight and body fat distribution. Cochrane Database Syst Rev 2000;2:CD1001018., , .